Last reviewed · How we verify
efavirenz; didanosine EC; lamivudine
efavirenz; didanosine EC; lamivudine is a Small molecule drug developed by Bristol-Myers Squibb. It is currently in Phase 1 development.
At a glance
| Generic name | efavirenz; didanosine EC; lamivudine |
|---|---|
| Sponsor | Bristol-Myers Squibb |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study of Cobicistat-Boosted Atazanavir (ATV/co), Cobicistat-Boosted Darunavir (DRV/co) and Emtricitabine/Tenofovir Alafenamide (F/TAF) in Children With HIV (PHASE2, PHASE3)
- A Study to Provide Continued Access to Study Drug to Children and Adolescents Who Have Completed Clinical Studies Involving Gilead HIV Treatments (PHASE4)
- A Prospective Cohort of Children With HIV Infection
- Preventing Sexual Transmission of HIV With Anti-HIV Drugs (PHASE3)
- Anti-HIV Drugs for Treating Infants Who Acquired HIV Infection at Birth (PHASE3)
- Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV (NA)
- The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs (PHASE2)
- Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320 (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- efavirenz; didanosine EC; lamivudine CI brief — competitive landscape report
- efavirenz; didanosine EC; lamivudine updates RSS · CI watch RSS
- Bristol-Myers Squibb portfolio CI
Frequently asked questions about efavirenz; didanosine EC; lamivudine
What is efavirenz; didanosine EC; lamivudine?
efavirenz; didanosine EC; lamivudine is a Small molecule drug developed by Bristol-Myers Squibb.
Who makes efavirenz; didanosine EC; lamivudine?
efavirenz; didanosine EC; lamivudine is developed by Bristol-Myers Squibb (see full Bristol-Myers Squibb pipeline at /company/bristol-myers-squibb).
What development phase is efavirenz; didanosine EC; lamivudine in?
efavirenz; didanosine EC; lamivudine is in Phase 1.